ZyVersa Therapeutics Inc (ZVSA)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | ||||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -499k | -985k | -4.59M | -17.05M | -2.9M | -1.78M | -2.83M | -2.75M |
| Pre Tax Income | -394k | -631k | -4.59M | -86.33M | -2.9M | -13.94M | -2.83M | -2.75M |
| Net Income | -394k | -679k | -3.54M | -86.43M | -2.93M | -13.34M | -2.83M | -2.76M |
| Preferred Dividends | 0 | 0 | 0 | -7.92M | -32k | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -499k | -985k | -4.59M | -17.05M | -2.9M | -1.78M | -2.83M | -2.75M |
| EBITDA | -499k | -985k | -4.59M | -5.15M | -2.9M | -1.78M | -2.82M | -2.75M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -235k | -820k | -26.32M |
| Pre Tax Income | -241k | -820k | -107.75M |
| Net Income | -241k | -75k | -106.25M |
| Preferred Dividends | 0 | 0 | -7.95M |
| Basic Earnings Per Share (EPS) | -0.097 | -0.004 | -1.984 |
| EBIT | -235k | -820k | -26.32M |
| EBITDA | -235k | -819k | -14.41M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
